Risk Factors and Preventive Interventions for Preeclampsia: A Literature Review
DOI:
https://doi.org/10.36557/2674-8169.2024v6n8p100-109Keywords:
Risk Factors; Preventive Interventions; Preeclampsia.Abstract
The evaluation of the efficacy and safety of interventions for the prevention of preeclampsia requires a comprehensive approach that considers both the benefits and potential risks associated with these strategies. A detailed analysis of risk factors and preventive interventions is essential to ensure that the measures adopted provide adequate protection against preeclampsia, while minimizing any potential adverse effects on maternal and fetal health.
The efficacy of preventive interventions is measured by their ability to reduce the incidence of preeclampsia, preventing severe complications such as severe hypertension, renal damage, and preterm birth. New approaches and treatments are constantly being developed to improve early detection and management of preeclampsia, as well as to provide a better quality of life for pregnant women. Clinical and laboratory studies are fundamental to testing these aspects, ensuring that new interventions deliver the promised protection.
The safety of treatments and preventive interventions is a constant concern. Medications such as low-dose aspirin, calcium supplementation, and other therapies have been the focus of studies to assess their potential to cause adverse effects on both the mother and the fetus. Continuous research and regulatory review are crucial to ensuring that the treatments available on the market are safe for long-term use, especially considering frequent use in vulnerable populations.
In addition to efficacy and safety for pregnant women, the sustainability and feasibility of preventive interventions are also important aspects. Prevention strategies such as lifestyle modifications, healthy eating, and rigorous blood pressure monitoring are non-invasive methods that can be widely applied. Therefore, there is a growing movement to develop interventions that are safe, effective, and accessible to all pregnant women.
In summary, the evaluation of the efficacy and safety of preventive interventions for preeclampsia is a complex process that involves multiple facets, from risk reduction and treatment safety to the sustainability of the strategies applied. An integrated and continuous approach to research and development is essential to ensure that preventive interventions provide effective and safe protection, contributing to public health and the quality of life for pregnant women.
Downloads
References
CORMICK, Gabriela; ZAHROH, Rana Islamiah; ALLOTEY, John; et al. Factors affecting the implementation of calcium supplementation strategies during pregnancy to prevent pre-eclampsia: a mixed-methods systematic review. BMJ Open, v. 13, n. e070677, 2023.
HAUGE, Maria G.; DAMM, Peter; KOFOED, Klaus F.; et al. Early coronary atherosclerosis in women with previous preeclampsia. American Journal of Obstetrics & Gynecology Maternal-Fetal Medicine, v. 11, p. 2310-2321, 2024.
ILIZALITURRI, Ana Ortiz; JIMENEZ, Krystal; TREJO, Raul; SERPAS, Shaila. A quality improvement project in family medicine residency training: improving preeclampsia prevention through risk factor screening and low-dose aspirin. American Journal of Public Health, v. 114, n. S4, p. S318-S321, 2024.
JIN, Min; SUN, Yongye. Maternal iron status and pre-eclampsia: study of iron metabolism and its association with pre-eclampsia. Asia Pacific Journal of Clinical Nutrition, v. 33, n. 2, p. 185-192, 2024.
LIU, Jiao; SHEN, Lixia; NGUYEN-HOANG, Long; et al. Aspirin versus metformin in pregnancies at high risk of preterm pre-eclampsia in China (AVERT): protocol for a multicentre, double-blind, 3-arm randomised controlled trial. BMJ Open, v. 14, n. e074493, 2024.
PADHAN, Satish C.; PRADHAN, Pranati; PANDA, Bharati; PRADHAN, Subrat K.; MISHRA, Sanjeeb K. Risk Factors of Pre-eclampsia: A Hospital-Based Case-Control Study. Cureus, v. 15, n. 7, e42543, 2023.
PITILIN, Eliane de Brito; et al. Study on inflammatory parameters in pre-eclampsia patients: methodology and clinical implications. BMC Pregnancy and Childbirth, v. 24, n. 71, p. 71-80, 2024.
SHANMUGALINGAM, Preethi; et al. Long-term outcomes in offspring whose mothers had preeclampsia: a review of clinical evidence. Frontiers in Medicine, v. 9, n. 984291, 2024.
VINOGRADOV, Raya; et al. Barriers and facilitators of adherence to low-dose aspirin during pregnancy: A co-produced systematic review and COM-B framework synthesis of qualitative evidence. PLOS ONE, v. 19, n. 5, e0302720, 2024.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Maria Clara Coutinho Bernabé, Victória Albani Cassa, Sthéfane Nascimento Rifor, Anderson da Silva Netto , Regina Célia Marcelino

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors are copyright holders under a CCBY 4.0 license.



